None
SEDAR Interim Financial Statements
NIRV · Price
[
{
"companyName": "NIRVANA LIFE SCIENCES INC.",
"reportingPeriodEnd": "2025-10-31",
"reportStatus": "Unaudited",
"auditorName": null,
"auditorKeyMatters": [],
"balanceSheet": {
"cash": 1856,
"salesTaxRecoverable": 18712,
"prepaidExpenses": null,
"totalAssets": 20568,
"accountsPayableAndAccruedLiabilities": 168581,
"amountsDueToRelatedParties": 287312,
"loanPayableToRelatedParty": 137126,
"totalLiabilities": 593019,
"shareCapital": 7875885,
"shareSubscriptionProceeds": 0,
"shareBasedPaymentsReserve": 559556,
"deficit": -9043583,
"equityAttributableToShareholders": -608598,
"nonControllingInterests": -5437,
"totalEquity": -613587,
"cashPerShare": 0.0001,
"workingCapitalPerShare": -0.0250
},
"incomeStatement": [
{
"period": "Three Months Ended October 31, 2025",
"accountingAndAudit": 34010,
"consulting": null,
"depreciation": 0,
"investorRelations": 368,
"legalFees": null,
"loanInterest": 0,
"managementFees": 45000,
"marketingAndPromotion": 314,
"officeAndMiscellaneous": 663,
"professionalFees": 0,
"rent": 0,
"researchAndDevelopment": null,
"shareBasedPayments": null,
"transferAgentAndFilingFees": 4309,
"lossBeforeItemsBelow": -90836,
"interestIncome": 0,
"gainOnDebtSettlement": 0,
"lossOnAcquisitionOfAssets": 0,
"lossAndComprehensiveLoss": -90837,
"lossAttributableToEquityHolders": -90837,
"lossAttributableToNonControllingInterests": -6,
"lossPerShare": 0,
"weightedAverageSharesOutstanding": 22932301
},
{
"period": "Three Months Ended October 31, 2024",
"accountingAndAudit": 10000,
"consulting": null,
"depreciation": 0,
"investorRelations": 617,
"legalFees": null,
"loanInterest": 665,
"managementFees": 45000,
"marketingAndPromotion": 506,
"officeAndMiscellaneous": 767,
"professionalFees": 0,
"rent": 0,
"researchAndDevelopment": null,
"shareBasedPayments": null,
"transferAgentAndFilingFees": 5559,
"lossBeforeItemsBelow": -61327,
"interestIncome": 0,
"gainOnDebtSettlement": 0,
"lossOnAcquisitionOfAssets": 0,
"lossAndComprehensiveLoss": -61327,
"lossAttributableToEquityHolders": -61228,
"lossAttributableToNonControllingInterests": -99,
"lossPerShare": 0,
"weightedAverageSharesOutstanding": 48233010
},
{
"period": "Six Months Ended October 31, 2025",
"accountingAndAudit": 34010,
"consulting": null,
"depreciation": 0,
"investorRelations": null,
"legalFees": null,
"loanInterest": 0,
"managementFees": 90000,
"marketingAndPromotion": null,
"officeAndMiscellaneous": 1216,
"professionalFees": null,
"rent": null,
"researchAndDevelopment": null,
"shareBasedPayments": null,
"transferAgentAndFilingFees": 9456,
"lossBeforeItemsBelow": -141250,
"interestIncome": 0,
"gainOnDebtSettlement": 14000,
"lossOnAcquisitionOfAssets": null,
"lossAndComprehensiveLoss": -127252,
"lossAttributableToEquityHolders": -127244,
"lossAttributableToNonControllingInterests": -8,
"lossPerShare": -0.01,
"weightedAverageSharesOutstanding": 22932301
},
{
"period": "Six Months Ended October 31, 2024",
"accountingAndAudit": 14000,
"consulting": null,
"depreciation": 0,
"investorRelations": null,
"legalFees": null,
"loanInterest": null,
"managementFees": 90000,
"marketingAndPromotion": null,
"officeAndMiscellaneous": 1430,
"professionalFees": null,
"rent": null,
"researchAndDevelopment": null,
"shareBasedPayments": null,
"transferAgentAndFilingFees": 9250,
"lossBeforeItemsBelow": -117486,
"interestIncome": 0,
"gainOnDebtSettlement": 0,
"lossOnAcquisitionOfAssets": null,
"lossAndComprehensiveLoss": -117468,
"lossAttributableToEquityHolders": -117277,
"lossAttributableToNonControllingInterests": -190,
"lossPerShare": -0.01,
"weightedAverageSharesOutstanding": 48233010
}
],
"cashFlowStatement": [
{
"period": "Six Months Ended October 31, 2025",
"netLoss": -141251,
"accruedLoanInterest": 0,
"depreciation": 0,
"gainOnDebtSettlement": 14000,
"lossOnAcquisitionOfAssets": 0,
"shareBasedPayments": 0,
"changeInSalesTaxRecoverable": 2266,
"changeInPrepaidExpenses": 0,
"changeInAccountsPayableAndAccruedLiabilities": -130872,
"changeInAmountsDueToRelatedParties": -761170,
"netCashUsedInOperatingActivities": -1017682,
"proceedsFromIssuanceOfShareCapital": 950000,
"loanFromRelatedParty": 66607,
"repaymentOfRelatedPartyLoan": 0,
"loanInterestPaid": 0,
"netCashProvidedByFinancingActivities": 1015827,
"changeInCash": -821,
"cashBeginning": 2677,
"cashEnd": 1856
},
{
"period": "Six Months Ended October 31, 2024",
"netLoss": -117486,
"accruedLoanInterest": null,
"depreciation": null,
"gainOnDebtSettlement": 0,
"lossOnAcquisitionOfAssets": null,
"shareBasedPayments": null,
"changeInSalesTaxRecoverable": -174,
"changeInPrepaidExpenses": null,
"changeInAccountsPayableAndAccruedLiabilities": -27984,
"changeInAmountsDueToRelatedParties": 87884,
"netCashUsedInOperatingActivities": -29775,
"proceedsFromIssuanceOfShareCapital": 0,
"loanFromRelatedParty": 42884,
"repaymentOfRelatedPartyLoan": null,
"loanInterestPaid": null,
"netCashProvidedByFinancingActivities": 42884,
"changeInCash": -2363,
"cashBeginning": 3014,
"cashEnd": 651
}
],
"investmentsAndOtherAssets": [
{
"type": "Subsidiary",
"description": "1253766 B.C. Ltd. (1253BC)",
"ownershipPercentage": 99.34,
"value": null,
"notes": "Wholly-owned subsidiary, consolidated"
},
{
"type": "Subsidiary",
"description": "Medsmart Dispensary Inc.",
"ownershipPercentage": 100,
"value": null,
"notes": "Wholly-owned subsidiary, acquired for 5,000,000 common shares valued at $175,000"
},
{
"type": "Loan Receivable",
"description": "Loan receivable from related party (significant shareholder)",
"ownershipPercentage": null,
"value": -319478,
"notes": "Fully impaired, allowance recorded for full amount due to collectability uncertainty"
}
],
"shareStructure": {
"authorizedShares": "unlimited",
"issuedShares": 22923301,
"classesOfShares": ["common"],
"warrants": [
{
"number": 50000,
"exercisePrice": 0.25,
"expiryDate": "2026-05-15"
},
{
"number": 320000,
"exercisePrice": 0.25,
"expiryDate": "2026-05-15"
}
],
"options": [
{
"number": 60000,
"exercisePrice": 5.5,
"expiryDate": "2027-05-01"
},
{
"number": 260000,
"exercisePrice": 1.5,
"expiryDate": "2028-05-01"
}
],
"rights/convertibleInstruments": null
},
"managementCompensation": {
"currency": "CAD",
"periods": {
"Six Months Ended October 31, 2024": {
"managementFees": 90000,
"consultingFees": 0,
"shareBasedPayments": 0,
"researchAndDevelopment": 0
}
},
"namedIndividuals": [],
"otherRelatedPartyTransactions": [
{
"counterparty": "Company controlled by CEO",
"description": "Management fees paid/accrued",
"amount": 90000,
"period": "Six Months Ended October 31, 2025"
},
{
"counterparty": "Companies affiliated with directors",
"description": "Loan received, unsecured, 10% interest, due November 30, 2025",
"amount": 40000,
"period": "2025-08-25"
},
{
"counterparty": "Officers and service provider",
"description": "Debt settlement via share issuance (18,000,000 common shares at $0.052 per share to settle $950,000 debt)",
"amount": 950000,
"period": "Three Months Ended July 31, 2025"
}
]
},
"subsequentEvents": []
}
]